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OR I G I N A L R E S E A R CH
Cyp2c44 gene disruption exacerbated pulmonary hypertension
and heart failure in female but not male mice
Sachindra Raj Joshi,1 Anand Lakhkar,1 Vidhi Dhagia,1 Ariadne L. Zias,1 Vasiliki Soldatos,1 Kaori Oshima,2 Houli Jiang,1
Katherine Gotlinger,1 Jorge H. Capdevila,3 Michal L. Schwartzman,1 Ivan F. McMurtry,2 Sachin A. Gupte1
1Department of Pharmacology, School of Medicine, New York Medical College, Valhalla, New York, USA; 2Department of Pharmacology, University of South
Alabama, Mobile, Alabama, USA; 3Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Abstract: Epoxyeicosatrienoicacids (EETs), synthesized from arachidonic acid by epoxygenases of the CYP2C and CYP2J gene subfamilies,
contribute to hypoxic pulmonary vasoconstriction (HPV) in mice. Despite their roles in HPV, it is controversial whether EETs mediate or
ameliorate pulmonary hypertension (PH). A recent study showed that deficiency of Cyp2j did not protect male and female mice from
hypoxia-induced PH. Since CYP2C44 is a functionally important epoxygenase, we hypothesized that knockout of the Cyp2c44 gene would
protect both sexes of mice from hypoxia-induced PH. We tested this hypothesis in wild-type (WT) and Cyp2c44 knockout (Cyp2c44−/−)
mice exposed to normoxia (room air) and hypoxia (10% O2) for 5 weeks. Exposure of WT and Cyp2c44
−/− mice to hypoxia resulted in
pulmonary vascular remodeling, increased pulmonary artery resistance, and decreased cardiac function in both sexes. However, in female
Cyp2c44−/− mice, compared with WT mice, (1) pulmonary artery resistance and right ventricular hypertrophy were greater, (2) cardiac
index was lower, (3) left ventricular and arterial stiffness were higher, and (4) plasma aldosterone levels were higher, but (5) there was no
difference in levels of EET in lungs and heart. Paradoxically and unexpectedly, we found that Cyp2c44 disruption exacerbated hypoxia-
induced PH in female but not male mice. We attribute exacerbated PH in female Cyp2c44−/− mice to elevated aldosterone and as-yet-
unknown systemic factors. Therefore, we suggest a role for the human CYP2C genes in protecting women from severe PH and that this
could be one of the underlying causes for a better 5-year survival rate in women than in men.
Keywords: arachidonic acid, cytochrome P450, aldosterone, sex, vascular remodeling.
Pulm Circ 2016;6(3):360-368. DOI: 10.1086/688060.
Pulmonary arterial hypertension (PAH) is a multifaceted disease
with poor prognosis and very high mortality rate.1 PAH has sex
bias and is more common in women than in men (in an approxi-
mate 3 ∶ 1 ratio).2,3 However, compared with men, women develop
less severe hypertension and have a better 5-year survival rate.3,4 In
both sexes, pulmonary artery constriction, remodeling, and inflam-
mation contribute to the pathogenesis of PAH.2,3 Damage to the endo-
thelium and endothelial dysfunction play critical roles in constricting
the blood vessels and contribute to pulmonary artery remodeling,
and both of these conditions increase pulmonary resistance and im-
pair blood flow through the lungs leading to PAH.5-8
Endothelium-derived autacoids, like nitric oxide and eicosa-
noids, are well-known regulators of vascular function.9 Nitric oxide
and prostacyclin relax adjacent smooth-muscle cells and prevent
smooth-muscle and endothelial cells from proliferating.9,10 Reduc-
tion of nitric oxide and prostacyclin levels has been associated with
the pathogenesis of PAH.11,12 Therefore, therapies that increase ni-
tric oxide or nitric oxide–dependent signaling and prostacyclin an-
alogs are standards of treatment for PAH.13
Epoxyeicosatrienoic acids (EETs), hyperpolarizing factors, are
produced by endothelial cytochrome P450 (CYP) epoxygenases.14
EETs protect coronary and pulmonary artery endothelial cells from
apoptosis, relax smooth-muscle cells, and dilate systemic arteries.15
Paradoxically, EETs elicit contraction of rat16 and rabbit17 pulmo-
nary arteries. However, their role in mediating pulmonary hyper-
tension (PH) is controversial. In mice, EETs are generated from
arachidonic acid by CYP2C9, CYP2C38, CYP2C39, CYP2C44, and
CYP2J5.18-20 The expression of CYP2C29 is increased in lungs of
hypoxic mice, and hypoxia-induced PH is potentiated by ectopic ex-
pression of CYP2C9, a human homologue, in mice.21 In contrast,
monocrotaline-induced inflammation and PH in rats are amelio-
rated by inhibition of soluble epoxide hydrolase and overexpression
of the Cyp2j5 gene,22,23 whereas deletion of the Cyp2j gene locus
does not attenuate the hypoxia-elicited pulmonary artery remod-
eling and hypertension in male and female mice.24 CYP2C29 and
CYP2J5 are equally expressed in hepatic and extrahepatic tissues of
both sexes, whereas CYP2C44 is expressed more in the kidneys and
adrenal glands of female mice than male mice.18-20 Since CYP2C44
shows a sex preference, we postulated that differential regulation of
CYP2C44 expression and activity could play a role in mediating less
severe PH in females versus males. To test this hypothesis, we ex-
posed Cyp2c44−/− mice of both sexes to hypoxia for 5 weeks. Our
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results suggest that Cyp2c44−/− exacerbated PH and heart failure in
female mice but not in male mice, and this was not mediated by de-
creased EETs but was potentially mediated by increased aldosterone.
METHODS
All experiments were performed following an institutional animal
care and use committee–approved protocol in accordance with the
National Institutes of Health Guidelines for the Care and Use of
Laboratory Animals. Male and female 129SvJ (weight: 25–30 g) wild-
type (WT) and Cyp2c44−/− mice were used in the study.
PH induction in mice
Mice were exposed to normobaric hypoxia (10% O2) in a ventilated
chamber for 5 weeks. The normoxic control mice were kept in
room air for all 5 weeks. At the end of the experiments, mice were
sacrificed, and lungs and heart were harvested for biochemical and
histological analyses.
Echocardiography
Echocardiography was performed in 2% isoflurane–anesthetized
mice using a Vevo 770 imaging system (VisualSonics, Toronto, On-
tario, Canada). In brief, at the beginning of the experiment (week 0)
and at the end of the experiment (week 5), two-dimensional para-
sternal short-axis view was obtained, M-mode assessment of left ven-
tricular function was performed, and left ventricular parameters were
measured as described previously.25 A two-dimensional parasternal
short-axis view at the level of the aortic valve was obtained, and a
pulsed-wave Doppler recording of the pulmonary artery blood flow
was recorded as described elsewhere.26 The ratio of pulmonary ar-
tery acceleration time (PAAT; time taken from start of flow to max-
imal velocity) to ejection time (ET; time taken from start of flow to
the end of flow) was determined as described previously.26,27 The
PAAT/ET ratio is inversely related to pulmonary vascular resistance.
Hemodynamic
Hemodynamic measurements were performed as described else-
where.28 Briefly, at the end of the experiment protocol (week 5),
the mice were anesthetized by 4% isoflurane, and 2% isoflurane was
used to maintain anesthesia for the entire duration of the surgery
and data acquisition. Body temperature of the animal during the
surgery was maintained using a heating pad. Approximately 3 cm2
of skin over the ventral neck region was exposed to locate and
carefully isolate the right common carotid artery. A 1.4F Millar
Micro-Tip pressure catheter was then inserted into the artery and
advanced into the left ventricle for measurement of left ventricular
hemodynamic parameters.
Liquid chromatography–tandem mass spectrometry
(LC-MS/MS) analysis of EETs
For the mass spectrometry analysis, we used heart and lungs from
Cyp2c44−/− and WT mice. Dissected lungs and hearts were then
weighed and submerged in liquid nitrogen, and their lipids were
extracted as described elsewhere.29 Lipid extracts were subjected to
alkaline hydrolysis, after which the eicosanoids present in lipid ex-
tracts were quantified by LC-MS/MS (Shimadzu Triple Quadrupole
Mass Spectrometer LCMS-8050 equipped with a Nexera ultra high
performance liquid chromatography (UHPLC) to monitor multiple
reaction). Mass spectrometry conditions were as follows. Ionization
mode: negative heated electrospray with applied voltage of −4.5
to approximately −3.0 kV; nebulizer gas: 3.0 L/min N2; drying gas:
5.0 L/min N2; heating gas: 12.0 L/min air; interface temperature:
400°C; desolvation lines temperature: 100°C; heat block tempera-
ture: 500°C; and internal standards: D6 20-hydroxyeicosatetraenoic
acid (HETE), D8 5-HETE, D4 prostoglandin E2 (PGE2), D11 11,12
DHET, D8 14(15) EET. UHPLC conditions were as follows. Analyt-
ical column: Zorbax Eclipse Plus C18 Rapid Resolution High Defi-
nition (50 mm L × 2.1 mm ID, 1.8 μm); mobile phase A: 95% water,
5% acetonitrile, 0.05% acetic acid; mobile phase B: acetonitrile 0.05%;
time program: 40% B (0 minutes)→75% B (3 minutes)→85% B
(7.5 minutes); flow rate: 0.4 mL/min; injection volume: 5 μL; and
column oven temperature: 40°C. Multiple reaction monitoring tran-
sitions were as follows. 20-HETE, CE 19.5 m/z: 319.2→289.2; D6
20-HETE, CE 19.0 m/z: 325.2→295.2; 15-HETE, CE 13.0 m/z:
319.2→219.2; 12-HETE, CE 13.5 m/z: 319.2→179.1; 5-HETE, CE
Table 1. Epoxyeicosatrienoic and dihydroxyeicosatetraenoic acids in heart and lungs of wild-type versus Cyp2c44 knockout (Cyp2c44−/−)
male and female mice
Epoxyeicosatrienoic and dihydroxyeicosatetraenoic acids, pg/μg protein
Heart Lungs
Male Female Male Female
Condition Wild type Cyp2c44−/− Wild type Cyp2c44−/− Wild type Cyp2c44−/− Wild type Cyp2c44−/−
Normoxia 273 ± 11 265 ± 23 99 ± 7 164 ± 40 119 ± 40 124 ± 17 104 ± 11 61 ± 6
Hypoxia 283 ± 19 369 ± 48 508 ± 203a 382 ± 83a 74 ± 10 193 ± 17 64 ± 10a 130 ± 15a
Note: Data are mean ± standard deviation.
a P < 0.05 versus normoxia; N = 5.
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15.0 m/z: 319.2→115.0; D8 5-HETE, CE 14.5 m/z: 327.5→116.0;
PGE2, CE 16.0 m/z: 351.1→271.2; D4 PGE2, CE 18.0 m/z:
355.3→275.2; D11 11,12 DHET, CE 21.0 m/z: 348.5→167.1; 14,15
DHET, CE 18.5 m/z: 337.3→207.1, 11,12 DHET, CE 19.5 m/z:
337.3→167.1; 8,9 DHET, CE 22.5 m/z: 337.3→145.0; 5,6 DHET,
CE 18.0 m/z: 337.3→145.0; D8 14(15) EET, CE 13.5 m/z:
330.3→218.9; 14(15) EET, CE 11.5 m/z: 319.2→219.2; 11(12) EET,
CE 14.5 m/z: 319.2→167.2; 8(9) EET, CE 16.5 m/z: 319.2→126.9;
and 5(6) EET, CE 319.2 m/z: 319.2→191.3.
Histology
Mice were euthanized and lungs and heart were harvested for mo-
lecular biological, biochemical, and histological analyses. The left
lung lobe was inflated with 0.5% agarose in 1% neutral buffered
formalin at 20 cm H2O pressure and fixed in 10% neutral buffered
formalin overnight.30 Formalin-fixed lung was blocked and em-
bedded in paraffin. Formalin-fixed, paraffin-embedded sections were
cut at 5 μm for the immunohistological analysis in the core histol-
ogy laboratory at New York Medical College. The inferior and post
caval lobes of the right lung were snap frozen for biochemical anal-
ysis. Hearts were fixed in formalin, and the right ventricle (RV)
and left ventricle plus septum (LV+S) were weighed for calculation
of RV/LV+S and used for hematoxylin and eosin staining.
Aldosterone assay
Aldosterone levels were measured in plasma samples obtained from
the Cyp2c44−/− and WT mice using an enzyme-linked immunosor-
bent assay kit (Abcam ab136933; Aldosterone ELISA Kit) accord-
ing to the manufacturer’s protocol.
Figure 1. Effect of chronic hypoxia on lung and heart remodeling and pulmonary vascular resistance in wild-type (WT) and Cyp2c44
knockout (Cyp2c44−/−) female and male mice. A, Representative micrographs of lung sections from normoxic (Norx) and hypoxic (Hypx)
WT and Cyp2c44−/− females and males stained with hematoxylin and eosin show medial thickening of arterial wall, perivascular cuffing,
and blood cells/thrombus in pulmonary vessels of hypoxic knockout mice. B, Summary data of pulmonary artery acceleration time to
ejection time ratio (PAAT/ET) ratio. C, Right ventricle (RV) hypertrophy determined by Fulton index in WT and Cyp2c44−/− group is
demonstrated. N = 5 in each group. Asterisk indicates P < 0.05 versus normoxia (Nor) controls, and pound sign indicates P < 0.05 versus
WT hypoxia. Magnification ×20. LV+S: left ventricle plus septum.
Figure 2. Effects of chronic hypoxia on cardiac hemodynamics in wild-type (WT) versus Cyp2c44 knockout (Cyp2c44−/−) female mice are
shown. Cardiac index (A), stroke volume (B), end-diastolic volume (C), and end-systolic volume (D) were decreased in hypoxic (Hypx)
WT and Cyp2c44−/− groups. However, deletion of Cyp2c44 gene exacerbated heart failure. N = 5 in each group. Asterisk indicates P < 0.05
versus normoxic (Norx) controls, and pound sign indicates P < 0.05 versus Hypx WT.
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Statistical analysis
Values are mean ± SEM of the number of samples (n) from dif-
ferent animals. Statistical analyses were performed with unpaired
Student t test, and a one-way ANOVA with Bonferroni correction
was used for comparing multiple groups. P < 0.05 was used to
establish statistical significance.
RESULTS
EETs synthesis in heart and lungs was not reduced
by Cyp2c44 gene disruption
All (14,15; 11,12; 8,9; 5,6) EETs and DHETs were quantitated in
the heart and lungs of control and hypoxic PH mice. Total EETs
(EETs+DHETs) in heart and lung tissues of male and female mice
were not reduced by Cyp2c44 gene ablation (Table 1). Interestingly,
total EETs were increased in the heart and lung tissues of chroni-
cally hypoxic WT and Cyp2c44−/− females but not in males.
Pulmonary vascular remodeling, pulmonary vascular
resistance, and right ventricle hypertrophy are
exacerbated by Cyp2c44 gene deletion in female mice
WT and Cyp2c44−/− female and male mice exposed to hypoxia for
5 weeks developed PH, compared with their normoxic controls.
Chronic hypoxia elicited pulmonary vascular remodeling, defined
as medial wall thickening of large arteries, in both WT and
Cyp2c44−/− female and male mice (Fig. 1A). In addition, we ob-
served marked perivascular cuffing and thrombosis and occluded
pulmonary vessels in Cyp2c44−/− hypoxia females and males but
not in WT normoxia females or males (Fig. 1A). We also found
that the PAAT/ET ratio, and RV hypertrophy (RV/LV+S) were,
respectively, decreased (Fig. 1B) and increased (Fig. 1C) in the
hypertensive Cyp2c44−/− females as compared with WT females. In-
terestingly, both the PAAT/ET ratio and RV hypertrophy were,
respectively, decreased and increased to the same degree in hyper-
tensive Cyp2c44−/− and WT males (Fig. 1D and 1E).
Heart function deteriorated more in Cyp2c44−/−
females exposed to chronic hypoxia
The heart function was determined by inserting a pressure-volume
Millar catheter into the LV. Cardiac index (CI; Fig. 2A), stroke
volume (SV; Fig. 2B), end-diastolic volume (EDV; Fig. 2C), and
end-systolic volume (ESV; Fig. 2D) were decreased more in hyper-
tensive Cyp2c44−/− than in WT female mice. In male mice, we did
not find any differences in hemodynamic parameters between the
hypertensive Cyp2c44−/− and WT groups (Table 2).
LV stiffness and systemic arterial elastance
are increased in Cyp2c44−/− females exposed
to chronic hypoxia
LV stiffness, calculated from the ratio of dP/dtmax to dV/dtmax, is
increased more in hypertensive Cyp2c44−/− females than in hyper-
tensive WT and Cyp2c44−/− controls (Fig. 3A), but no differences in
trichrome staining of the LV were noted among these groups
(Fig. 3B). In addition, systemic arterial elastance (Fig. 3C), a mea-
sure of large artery stiffness, and total peripheral vascular resistance
(Fig. 3D), calculated from dividing cardiac output by mean systemic
arterial pressure, were higher in hypertensive Cyp2c44−/− females
than in hypertensive WT and Cyp2c44−/− controls. In male mice,
the increases in LV stiffness and arterial elastance were not differ-
ent between the chronically hypoxic Cyp2c44−/− and WT mice (Ta-
ble 2).
Aldosterone levels are elevated in Cyp2c44−/−
female mice exposed to chronic hypoxia
Aldosterone plays a critical role in the homeostasis of blood vol-
ume and pressure31 as well as in heart and blood vessel remodel-








CI (mL/min/m2) 1,302 ± 89.38 308.1 ± 19.03a 1,344 ± 114.8 304.6 ± 36.01a
SV (μL) 29.83 ± 1.50 5.90 ± 0.91a 28.50 ± 2.09 6.03 ± 0.50
EDV (μL) 84.78 ± 2.28 26.31 ± 2.56a 72.96 ± 3.59 29.00 ± 2.59a
ESV (μL) 60.20 ± 2.71 21.62 ± 1.87a 48.64 ± 2.45 25.21 ± 2.39a
LV stiffness (mmHg/μL) 4.31 ± 0.17 21.89 ± 4.91a 4.43 ± 0.15 18.26 ± 3.85a
Ea (mmHg/μL) 3.57 ± 0.13 14.63 ± 2.22a 3.10 ± 0.22 14.49 ± 1.82a
TPR (mmHg × min/mL) 7.58 ± 0.38 34.51 ± 4.38a 6.92 ± 0.55 34.20 ± 2.90a
Note: Data are mean ± standard deviation. CI: cardiac index; Ea: arterial elastance; EDV: end-diastolic volume; ESV: end-systolic
volume; LV: left ventricle; SV: stroke volume; TPR: total peripheral resistance.
a P < 0.05 versus control; N = 5.
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ing in animals and humans.32 Earlier studies have shown that high
plasma aldosterone levels correlate well with remodeling of the
heart, but more so in women than in men.33 Because angiotensin
II and blood levels of Na+ and K+ regulate synthesis of aldosterone,
we estimated aldosterone in plasma samples obtained from control
and PH WT and Cyp2c44−/− female and male mice. Aldosterone
levels in females were decreased in PH versus control WT mice,
but they were increased in PH versus control Cyp2c44−/− mice
(Fig. 4). This increase in circulating aldosterone levels was not seen
in the male PH versus control Cyp2c44−/− mice (Table 3).
DISCUSSION
It is well known that PAH has a sex bias and that the disease is
more prevalent among women than men.2-4 In contrast, in several
animal models of PH, the severity of the hypertension is less in
females than in males.34,35 In this study of mice, we found that
disruption of the Cyp2c44 gene worsened the severity of PH in
females exposed to hypoxia, thus minimizing the apparent advan-
tage in their response to hypoxia. We also found that the exacer-
bated hypoxia-induced pulmonary vascular remodeling and heart
failure associated with disruption of the Cyp2c44 gene in female
mice were not due to a reduction in pulmonary or heart EETs but
were potentially linked to increases in the levels of circulating al-
dosterone.
The CYP family of enzymes expressed in hepatic and extra-
hepatic tissues metabolizes steroids, fatty acids, and drugs and has
diverse actions on cell and organ function.18,36 Overexpression of
the estrogen-metabolizing enzyme CYP1B1 in pulmonary arteries
has been implicated in the development of PH in mice, rats, and
humans.3,37-39 Estrogen-induced Cyp2c29 gene expression in female
mice increases vascular EET synthesis and blood vessel dilation in
the absence of nitric oxide.40 In contrast to these observations,
CYP2C29 expression is increased in the lungs of mice exposed to
hypoxia for 2 hours, and hypoxia-induced PH and pulmonary vas-
cular remodeling appear to be attenuated by continuous treatment
of mice with the expoxygenase inhibitor N-methylsufonyl-6-[2-
propargyloxyphenyl] hexanamide.21 Moreover, it was found that
overexpression of CYP2C9, a human epoxygenase homologue, in
mice elevates mean pulmonary arterial pressure and total pulmonary
vascular resistance and that disruption, but not inhibition, of soluble
epoxide hydrolase contributes to the pathophysiology of hypoxia-
induced pulmonary artery remodeling and PH.21,41 In contrast, other
studies have reported that inhibition of soluble epoxide hydrolase22
or overexpression of CYP2J523 reduce monocrotaline-induced pul-
monary vascular remodeling and PH in mice. Although it was re-
cently found that Cyp2j deficiency does not attenuate hypoxia-
induced PH in male and female mice, we now demonstrate that
knockout of CYP2C44 epoxygenase, which metabolizes arachidonic
Figure 3. Effects of chronic hypoxia on left ventricle and arterial stiffness in wild-type (WT) versus Cyp2c44 knockout (Cyp2c44−/−) female
mice are shown. Left ventricle stiffness (A), trichrome staining of left ventricle free wall (fibrosis; B), systemic arterial elastance (C), and
total peripheral vascular resistance (D) were increased in both hypoxic (Hypx) WT and Cyp2c44−/− groups. However, deletion of the
Cyp2c44 gene exacerbated ventricle and arterial stiffness and further increased total peripheral resistance. N = 5 in each group. Asterisk
indicates P < 0.05 versus normoxia (Norx) controls, and pound sign indicates P < 0.05 versus Hypx WT.
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acid predominantly to EETs, increases the severity of PH and heart
failure in female but not male mice.24
CYP2C44 has little homology with other mouse CYP2C expoxy-
genases but is highly homologous to the rat kidney CYP2C23.19
CYP2C44 is predominantly expressed in liver, kidneys, and adre-
nal glands.19 Moreover, expression of CYP2C44 messenger RNA in
kidneys and adrenal glands is 2-fold higher among females than
males. Our results indicate that deletion of the Cyp2c44 gene exac-
erbated PH-associated heart failure in females. Furthermore, peri-
vascular cuffing, an indication of edema, and the hemodynamic out-
come were more severe in Cyp2c44−/− females than in WT females
exposed to hypoxia for 5 weeks. This suggests that deletion of
Cyp2c44 gene exacerbated pulmonary vascular remodeling, RV hy-
pertrophy, LV and arterial stiffening, and reduction of CI.
CYP-derived EETs are hyperpolarizing factors that decrease the
membrane potential of vascular smooth-muscle cells and dilate re-
nal arteries and other systemic blood vessels.14,42 Paradoxically,
EETs constrict pressurized rabbit pulmonary arteries and increase
pulmonary arterial pressure.17,21,43 In isolated perfused human lungs,
it was observed that CYP-derived cis-EETs released into the vascu-
lar space by A23187 and inflammatory challenge correlated with
the vasopressor response.44 In this study, we observed that Cyp2c44
deletion did not significantly reduce EET levels in heart or lungs of
either sex. Instead, EETs increased in heart and lungs of Cyp2c44−/−
PH females but not males. This indicates that the synthesis of EETs
by CYP2C29 or other CYP epoxygenases expressed in lungs and
heart was increased in hypertensive females. Alternatively, circulat-
ing EETs through a paracrine action, like hormones or cytokines,
stimulate EET-associated receptor signaling in lungs and heart to
exacerbate PH in females. Nonetheless, we did not find a correla-
tion between EET levels and the pulmonary vascular resistance or
RV hypertrophy in males and females. All together, these results
suggest that EETs do not contribute significantly to the develop-
ment of hypoxia-induced PH or heart failure in mice.
On the basis of the lack of evidence for lung- or heart-derived
EETs in the pathogenesis of PH-associated heart failure, we specu-
lated that some factor other than CYP2C44-derived EETs played a
potential role in promoting pulmonary vascular remodeling and
suppressing cardiac function. CYP2C44 is expressed in the kidney,
and reduction of EETs resulting from the deletion of the Cyp2c44
gene increases the activity of epithelial Na+ channel (ENaC) in the
cortical collecting duct, which facilitates Na+ and K+ reabsorption
and modulates blood levels of these ions.19,45-48 Blood K+ levels
are critical determinants of the production of aldosterone, a min-
eralocorticoid hormone produced by the adrenal gland that in-
creases blood volume and blood pressure.49 To the best of our
knowledge, there is no evidence that CYP2C44 has a direct influ-
ence on the biosynthesis of aldosterone. Therefore, we postulated
that an increase of ENaC activity by disruption of CYP2C44 could
regulate circulating aldosterone levels. Our findings indicated that, in
normoxic control mice, aldosterone levels were lower in Cyp2c44−/−
females than in WT females. Furthermore, although aldosterone lev-
els were slightly but significantly decreased in WT mice, paradoxi-
cally, aldosterone increased in Cyp2c44−/− female mice exposed to
hypoxia for 5 weeks compared with their normoxic controls. Con-
comitantly, hypoxia-induced PH and heart failure were exacerbated
in Cyp2c44−/− female mice when compared with WT female mice.
Thus, these results suggest that disruption of the Cyp2c44 gene has
a consequence on aldosterone levels in the chronically hypoxic
females. Increased circulating levels of aldosterone are deleterious
to cardiovascular function and provoke pathogenic remodeling of
the cardiovascular system, whereas aldosterone levels correlate well
with remodeling of the heart, although more so in females than in
males.32,33 There is also an association between elevated plasma
aldosterone and Na+ levels with increased incidence of coagulation
and thrombotic events, which are mediated by aldosterone-induced
AT1R signaling and blocked by mineralocorticoid receptor antago-
nists.50-53 Along these line, thrombosis and occluded pulmonary ar-
Figure 4. Effect of chronic hypoxia on circulating aldosterone levels
in wild-type (WT) versus Cyp2c44 knockout (Cyp2c44−/−) female
mice is shown. Plasma aldosterone was increased in pulmonary hy-
pertensive Cyp2c44−/− as compared with normotensive control and
hypertensive WT group. Four mice were measured in duplicate in
each group. Asterisk indicates P < 0.05 versus normoxia (Norx)
controls, and pound sign indicates P < 0.05 versus Norx WT.
Hypx: hypoxic.
Table 3. Circulating aldosterone levels in wild-type versus Cyp2c44
knockout (Cyp2c44−/−) male mice
Circulating aldosterone, pg/mL
Condition Wild type Cyp2c44−/−
Normoxia 543 ± 35 546 ± 11
Hypoxia 611 ± 7a 556 ± 15
a P < 0.05 versus normoxia; N = 5.
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teries were apparent in hypoxic Cyp2c44−/− female mice but not WT
female mice. Thrombosis will increase pulmonary vascular resis-
tance, and thrombin-activated platelets will release platelet-derived
growth factor that will stimulate pulmonary artery remodeling. A
recent study found that aldosterone levels are elevated in patients
with idiopathic PAH, and the steroid has been proposed as a po-
tential biomarker.54 Furthermore, activation of the mineralocorti-
coid receptor contributes to pulmonary vascular and right ventricu-
lar remodeling of hypoxia- and monocrotaline-induced PH in mice
and rats, respectively.55 Therefore, we imply increased aldosterone
as one of the causes for the development of more severe hypoxia-
induced pulmonary vascular remodeling, RV hypertrophy, and LV
and systemic artery stiffness in Cyp2c44−/− female mice.
In summary, we have demonstrated that hypoxia-induced pul-
monary vascular remodeling and cardiac dysfunction are ampli-
fied by Cyp2c44 gene deletion in female, but not male, mice. This
raises the possibility that CYP2C44 could play a role in protecting
females from PH and could be one of the underlying causes for a
better 5-year survival rate among women than among men.
Source of Support: National Institutes of Health/National Heart,
Lung, and Blood Institute grant HL034300 to MLS.
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